When economic survival goes off course, abuses follow
In Harare and across Zimbabwe’s provinces, poultry farming has become a sideline for many households in an economy where every week counts. When margins are slim, the temptation is strong to shorten production cycles, increase chickens’ weight more quickly and limit losses. It is in this gap that dangerous practices thrive, sometimes going unnoticed until they affect public health.
Zimbabwe is not starting from scratch on this issue. For several years, health and agricultural authorities have warned about the excessive use of veterinary products and antimicrobials in the poultry sector. In 2024 and 2025, United Nations agencies and technical partners even stepped up work on antimicrobial resistance, or AMR — the ability of microbes to resist the medicines intended to stop them. The FAO said that a 2024–2028 national action plan and a roadmap to reduce antimicrobial use in poultry and dairy supply chains were being finalised.
An old rumour, but a very real risk
At the heart of the issue is an illegal practice that is difficult to quantify precisely: Zimbabwean farmers are reportedly giving their chickens antiretroviral drugs, or ARVs, intended for people living with HIV. The presumed idea is simple: to make poultry grow faster and reduce mortality. The practice was reported in Zimbabwe more than a decade ago by health and agricultural stakeholders, who warned at the time that stronger oversight of the sector was needed.
The practice remains difficult to document, as it often relies on anonymous accounts and a parallel market. But it has not come out of nowhere. In Zimbabwe, episodes of drug shortages, informal channels and economic pressure create favourable conditions for people to circumvent the rules. In 2025, UNAIDS was still reporting disruptions linked to US funding, with effects on human resources, prevention and some care services. ARV stocks remained available at several facilities, but distribution and support systems remained vulnerable.
Zimbabwe remains strongly committed to its HIV response. The National AIDS Council puts the number of people living with HIV at about 1.3 million, with 97% knowing their status, 98% on treatment and 96% with a suppressed viral load. In late 2025, UNDP, together with the Global Fund, reported that 1,230,298 people, adults and children, were receiving antiretroviral therapy, or 94.95% of the estimated number of people living with HIV in the country. In other words, the system is still holding, but is ill-equipped to withstand diversion and funding shocks.
What this practice really threatens
The first risk affects patients. ARVs are long-term medicines, taken regularly to prevent the virus from replicating. If residues enter the food chain, experts interviewed in local investigations say they could contribute to unnecessary exposure to the drugs and, in time, complicate treatment management. This is not definitive scientific proof of a direct link to resistance, but it is a serious enough warning sign to warrant caution and oversight.
The second risk concerns confidence in food. In a country where poultry is an affordable source of protein, urban and peri-urban consumers are the first to be exposed if veterinary checks are circumvented. Small producers, meanwhile, face a two-tier system: those who follow the rules bear higher costs, while those who cheat can undercut prices in the short term. This pressure fuels unfair competition and weakens formal supply chains, already strained by the cost of inputs and economic volatility.
The third risk is institutional. Zimbabwe has strengthened its efforts against AMR, with support from the FAO and WHO, by adopting the “One Health” approach, which links human, animal and environmental health. This framework is relevant because it avoids treating patients’ health, livestock health and food safety separately. But it requires resources, monitoring and regular inspections. Without them, warnings remain theoretical.
A local issue with regional repercussions
The issue extends beyond Zimbabwe’s borders. In Southern Africa, SADC has already stressed that health and food systems are closely linked. When external funding contracts, countries reliant on technical and logistical support see grey areas emerge: diverted medicines, informal markets, inadequate checks and increased health risks. The case of Zimbabwe is therefore a regional warning, not an isolated one.
The political dimension also deserves attention. In February 2026, the United States announced that it was ending its health assistance project in Zimbabwe after talks on data sharing failed, while Washington had cited a $367m package over five years for priority health programmes, including HIV. This potential rupture puts pressure on the treatment, prevention and monitoring ecosystem. When official channels weaken, parallel channels gain ground.
Zimbabwean authorities now face a twofold challenge. They must secure access to ARVs for the people who rely on them every day. They must also clean up the poultry sector by combining veterinary checks, traceability, training for small-scale farmers and penalties for illicit channels. Across Africa, the issue is a reminder of a simple reality: public health is defended not only in hospitals. It is also at stake in markets, farms and supply chains. In Zimbabwe, this frontline runs through Harare, but its effects are felt far beyond.



